文献速递免疫规划传染病防控与疫情报告

李斯特菌溶血素O亚单位疫苗对单核细胞增生李斯特菌感染具有保护作用

A listeriolysin O subunit vaccine is protective against Listeria monocytogenes.
PubMed 文献 · Vaccine · 2020-07-17

本研究制备了胆固醇识别基序突变的全长李斯特菌溶血素O类毒素(LLOT),使其丧失成孔能力但保留细胞表面结合能力。小鼠免疫实验显示,LLOT联合霍乱毒素佐剂可显著降低感染后肝脏和脾脏的细菌负荷,而单用LLOT或联合铝佐剂无保护作用。保护性免疫依赖T细胞而非B细胞,并伴随Th1、Th2、Th17混合应答及LLO中和抗体产生。

要点

  • LLOT保留抗原提呈细胞捕获能力但丧失胆固醇结合与成孔活性。
  • LLOT联合霍乱毒素佐剂可降低感染小鼠肝脾细菌负荷。
  • 保护性免疫需要T细胞,B细胞在非妊娠年轻小鼠模型中非必需。

核心结论

  • LLOT是诱导抗单核细胞增生李斯特菌保护性免疫的有前景的亚单位疫苗抗原,需含Th1驱动佐剂。

研究设计与样本

  • 研究构建了胆固醇识别基序突变的LLOT,并在小鼠模型中比较单用LLOT、LLOT联合霍乱毒素或铝佐剂免疫后的保护效果。

主要发现

  • LLOT丧失胆固醇结合和成孔能力,但仍结合上皮细胞和巨噬细胞表面。
  • 单用LLOT或联合铝佐剂免疫的小鼠未获保护。
  • LLOT联合霍乱毒素免疫的小鼠感染后3天肝脾细菌负荷显著降低。
  • 该免疫方案诱导混合Th1、Th2、Th17应答及LLO中和抗体。
  • T细胞为免疫诱导细菌负荷降低所必需,B细胞在非妊娠年轻小鼠模型中非必需。

临床怎么用

  • LLOT联合Th1驱动佐剂可作为抗李斯特菌亚单位疫苗的候选方案,但尚需临床前进一步验证。

局限性

  • 保护效果仅在非妊娠年轻小鼠模型中验证,未涉及妊娠或免疫缺陷宿主。
  • 所用霍乱毒素为实验性佐剂,尚未适用于人体。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Listeria monocytogenes is a facultative intracellular pathogen responsible for the life-threatening disease listeriosis. The pore-forming toxin listeriolysin O (LLO) is a critical virulence factor that plays a major role in the L. monocytogenes intracellular lifecycle and is indispensable for pathogenesis. LLO is also a dominant antigen for T cells involved in sterilizing immunity and it was proposed that LLO acts as a T cell adjuvant. In this work, we generated a novel full-length LLO toxoid (LLOT) in which the cholesterol-recognition motif, a threonine-leucine pair located at the tip of the LLO C-terminal domain, was substituted with two glycine residues. We showed that LLOT lost its ability to bind cholesterol and to form pores. Importantly, LLOT retained binding to the surface of epithelial cells and macrophages, suggesting that it could efficiently be captured by antigen-presenting cells. We then determined if LLOT can be used as an antigen and adjuvant to protect mice from L. monocytogenes infection. Mice were immunized with LLOT alone or together with cholera toxin or Alum as adjuvants. We found that mice immunized with LLOT alone or in combination with the Th2-inducing adjuvant Alum were not protected against L. monocytogenes. On the other hand, mice immunized with LLOT along with the experimental adjuvant cholera toxin, were protected against L. monocytogenes, as evidenced by a significant decrease in bacterial burden in the liver and spleen three days post-infection. This immunization regimen elicited mixed Th1, Th2, and Th17 responses, as well as the generation of LLO-neutralizing antibodies. Further, we identified T cells as being required for immunization-induced reductions in bacterial burden, whereas B cells were dispensable in our model of non-pregnant young mice. Overall, this work establishes that LLOT is a promising vaccine antigen for the induction of protective immunity against L. monocytogenes by subunit vaccines containing Th1-driving adjuvants.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Phelps CC, Vadia S, Boyaka PN, et al. A listeriolysin O subunit vaccine is protective against Listeria monocytogenes. Vaccine. 2020. PMID: 32684498. doi:10.1016/j.vaccine.2020.06.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。